100
Participants
Start Date
July 30, 2018
Primary Completion Date
March 20, 2023
Study Completion Date
December 1, 2023
Regorafenib (Stivarga, BAY73-4506)
The recommended dose of regorafenib is 160 mg (consisting of 4 tablets, each containing 40 mg of regorafenib) for 3 weeks of every 4 week cycle, (ie. 3 weeks on therapy, 1 week off therapy).
Sir Ganga Ram Hospital, New Delhi
Shalby Hospital, Ahmedabad
Healthcare Center Global Hospital, Ahmedabad
Tata Memorial Hospital, Mumbai
Jaslok Hospital and Research Centre, Mumbai
Sushrut Hospital & Research Centre, Mumbai
Fortis Hospital, West-Mumbai
Jehangir Hospital, Pune
Apollo Research Foundation, Hyderabad
Apollo Speciality Hospitals, Madurai
IPGME & R / SSKM Hospital, Kolkata
Health Point Hospital, Kolkata
Sparsh Hospital & Critical Care, Bhubaneswar
Lead Sponsor
Bayer
INDUSTRY